Suppr超能文献

用于皮肤致敏剂鉴定和分类的比勒试验的实验室间评估。

An interlaboratory evaluation of the Buehler test for the identification and classification of skin sensitizers.

作者信息

Basketter D A, Gerberick G F

机构信息

Unilever Environmental Safety Laboratory, Sharnbrook, Bedford, UK.

出版信息

Contact Dermatitis. 1996 Sep;35(3):146-51. doi: 10.1111/j.1600-0536.1996.tb02332.x.

Abstract

The correct identification of potential skin sensitizers is an essential first step in enabling a proper risk assessment to be made and to permit the implementation of appropriate risk management practices designed to avoid the induction of sensitization. Consequently, regulatory guidelines around the world demand that new substances are evaluated to assess their skin sensitization potential. There are two guinea pig test methods which are generally recognised, the guinea pig maximisation test (GPMT) and the occluded patch test described by Buehler. In different countries, one procedure seems to be more prevalent and acceptable to regulatory authorities than the other. Notably, in the European Union, the latest revision of the Annex V (Directive 92/32/EC) Test Method for skin sensitization asks that justification should be given in the situation where the notifier does not use the GPMT, which is the preferred method. Thus in this paper, the validity of the Buehler protocol in the context of European legislation is critically examined. Results from two laboratories are collated, showing that the method can identify significant contact allergens, particularly those which would be registered formally as such according to European legislation. It is demonstrated that minor methodological variations can be tolerated without compromising test sensitivity, but it is recommended that suitable positive control testing is the best way to ensure proper test conduct.

摘要

正确识别潜在的皮肤致敏剂是进行恰当风险评估以及实施旨在避免致敏反应的适当风险管理措施的关键第一步。因此,世界各地的监管指南都要求对新物质进行评估,以确定其皮肤致敏潜力。目前普遍认可两种豚鼠试验方法,即豚鼠最大化试验(GPMT)和Buehler描述的封闭斑贴试验。在不同国家,一种方法似乎比另一种方法在监管机构中更普遍且更易被接受。值得注意的是,在欧盟,附件V(指令92/32/EC)皮肤致敏试验方法的最新修订要求,如果申报者未使用首选方法GPMT,则应说明理由。因此,本文对Buehler试验方案在欧洲法规背景下的有效性进行了严格审查。整理了两个实验室的结果,表明该方法能够识别重要的接触性过敏原,特别是那些根据欧洲法规将被正式登记为接触性过敏原的物质。结果表明,在不影响试验敏感性的情况下,可以容忍较小的方法学差异,但建议进行适当的阳性对照试验是确保试验正确进行的最佳方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验